STAT3 and glioblastoma: INPP5F deletion is correlated with a decreased survival rate for glioma patients, and overexpressed INPP5F suppresses glioblastoma cell proliferation, GSCs' self-renewal, and gliomagenesis through inhibition of STAT3 pathway.